KGA 0941

Drug Profile

KGA 0941

Latest Information Update: 12 Dec 2006

Price : $50

At a glance

  • Originator Kyorin Pharmaceutical
  • Class
  • Mechanism of Action Serotonin 3 receptor antagonists; Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gastrointestinal disorders

Most Recent Events

  • 26 May 2001 No-Development-Reported for Gastrointestinal disorders in Japan (Unknown route)
  • 11 Feb 1998 Preclinical development for Gastrointestinal disorders in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top